COVID-19 Resources - QuickVue At-Home

COVID-19 Resources

Logo for QuickVue At-Home OTC COVID-19 Test

What happens if I receive a positive test result?

If you test positive with the QuickVue At-Home OTC COVID-19 Test, then proteins from the virus that causes COVID-19 has been found in your sample and you likely have COVID-19.

Per CDC recommendations, you should self-isolate at home to help stop the spread of the virus to others. For the latest CDC recommendations and updates, visit the CDC website »

Sample Image of Positive Test Results

The QuickVue At-Home OTC COVID-19 Test expiration extension

The QuickVue At-Home OTC COVID-19 Test has been granted FDA EUA authorization to extend expiration dating from 12 months to 16 months. A copy of the letter is available here. Please note the expiration dates on the outer kit box may not reflect the 16-month dating for product that is already distributed.

Is your test nearing its expiration date?

To verify if the expiration date for a particular lot has been extended:

  • Go to the FDA webpage »
  • Scroll down to view the list of lot numbers with updated expiration dating. You will require the lot number on your test kit box.
Lot number is found on back of package.
Lot number and barcode on back of product package

You are about to leave the QuidelOrtho website for a third-party site. Links which take you outside of the QuidelOrtho website are not under QuidelOrtho’s control, and QuidelOrtho is not responsible for any content or links contained therein. QuidelOrtho is providing these links to you only as a convenience, and such provision does not imply an endorsement by QuidelOrtho of any linked site. Any information you provide to a third-party site will be governed by the third-party’s website Terms of Use, including those related to confidentiality, data privacy and security.

Our QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance by the U.S. FDA under a new name – QuickVue COVID 19-Test.

The QuickVue At-Home OTC COVID-19 Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.

This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older or adult-collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first six days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. The QuickVue At-Home OTC COVID-19 Test does not differentiate between SARS-CoV and SARS-C0V-2.

*In the USA, this product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Partners of:

  • San Diego Padres logo
    San Diego Padres
  • San Diego Loyal logo
    San Diego Loyal
  • Chicago Blackhawks logo
    Chicago Blackhawks
  • Los Angeles Rams logo
    Los Angeles Rams